FDA approves ointment for treatment of mild-to-moderate psoriasis.
(2/3, DeNoon) reported that the Food and Drug Administration (FDA) has approved Vectical (calcitriol), an "ointment containing...the active form of vitamin D3," for "use by adults 18 and older with mild-to-moderate psoriasis." In clinical trials, Vertical was demonstrated to be "safe during one year of continuous use." Side effects of the drug "include changes in the way the body uses calcium." Therefore, patients "with known or suspected disturbances in calcium metabolism are warned to use Vectical with caution," as well as those who take drugs, "such as thiazide diuretics, that affect calcium levels." In addition, "caution is...advised for patients taking calcium or vitamin D supplements." A "possible advantage" of calcitriol is "that it can be applied to sensitive skin-fold areas."
(2/4) also reports the story.
No comments:
Post a Comment